Nanotechnology Assisted Drug Delivery Strategies for Chemotherapy: Recent Advances and Future Prospects.

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS
ACS Applied Bio Materials Pub Date : 2025-05-19 Epub Date: 2025-05-03 DOI:10.1021/acsabm.5c00046
Pavan K Yadav, Divya Chauhan, Pooja Yadav, Amrendra K Tiwari, Nazneen Sultana, Deepak Gupta, Keerti Mishra, Jiaur R Gayen, Muhammad Wahajuddin, Manish K Chourasia
{"title":"Nanotechnology Assisted Drug Delivery Strategies for Chemotherapy: Recent Advances and Future Prospects.","authors":"Pavan K Yadav, Divya Chauhan, Pooja Yadav, Amrendra K Tiwari, Nazneen Sultana, Deepak Gupta, Keerti Mishra, Jiaur R Gayen, Muhammad Wahajuddin, Manish K Chourasia","doi":"10.1021/acsabm.5c00046","DOIUrl":null,"url":null,"abstract":"<p><p>In pursuit of the treatment of cancer, nanotechnology engineering has emerged as the simplest and most effective means, with the potential to deliver antitumor chemotherapeutics at the targeted site. Employing nanotechnology for drug delivery provides diverse nanosize particles ranging from one to a thousand nanometers. Reduced size improves drug bioavailability by increasing drug diffusion and decreasing the efflux rate. These nanocarriers offer an enormous scope for modification following the chemical and biological properties of both the drug and its disease. Moreover, these nanoformulations assist in targeting pharmaceutically active drug molecules to the desired site and have gained importance in recent years. Their modern use has revolutionized the antitumor action of many therapeutic agents. Higher drug loading efficiency, thermal stability, easy fabrication, low production cost, and large-scale industrial production draw attention to the application of nanotechnology as a better platform for the delivery of drug molecules. Furthermore, the interaction of nanocarrier technology-assisted agents lowers a drug's toxicity and therapeutic dosage, reduces drug tolerance, and enhances active drug concentration in neoplasm tissue, thus decreasing the concentration in healthy tissue. Nanotechnology-based medications are being widely explored and have depicted effective cancer management <i>in vivo</i> and <i>in vitro</i> systems, leading to many clinical trials with promising results. This review summarizes the innovative impact and application of different nanocarriers developed in recent years in cancer therapy. Subsequently, it also describes the essential findings and methodologies and their effects on cancer treatment. Compared with conventional therapy, nanomedicines can significantly improve the therapeutic effectiveness of antitumor drugs. Thus, the adverse effects associated with healthy tissues are decreased, and adverse effects are scaled back through enhanced permeability and retention effects. Lastly, future insights assisting nanotechnology in active therapeutics delivery and their scope in cancer chemotherapeutics have also been discussed.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":" ","pages":"3601-3622"},"PeriodicalIF":4.6000,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1021/acsabm.5c00046","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/3 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

Abstract

In pursuit of the treatment of cancer, nanotechnology engineering has emerged as the simplest and most effective means, with the potential to deliver antitumor chemotherapeutics at the targeted site. Employing nanotechnology for drug delivery provides diverse nanosize particles ranging from one to a thousand nanometers. Reduced size improves drug bioavailability by increasing drug diffusion and decreasing the efflux rate. These nanocarriers offer an enormous scope for modification following the chemical and biological properties of both the drug and its disease. Moreover, these nanoformulations assist in targeting pharmaceutically active drug molecules to the desired site and have gained importance in recent years. Their modern use has revolutionized the antitumor action of many therapeutic agents. Higher drug loading efficiency, thermal stability, easy fabrication, low production cost, and large-scale industrial production draw attention to the application of nanotechnology as a better platform for the delivery of drug molecules. Furthermore, the interaction of nanocarrier technology-assisted agents lowers a drug's toxicity and therapeutic dosage, reduces drug tolerance, and enhances active drug concentration in neoplasm tissue, thus decreasing the concentration in healthy tissue. Nanotechnology-based medications are being widely explored and have depicted effective cancer management in vivo and in vitro systems, leading to many clinical trials with promising results. This review summarizes the innovative impact and application of different nanocarriers developed in recent years in cancer therapy. Subsequently, it also describes the essential findings and methodologies and their effects on cancer treatment. Compared with conventional therapy, nanomedicines can significantly improve the therapeutic effectiveness of antitumor drugs. Thus, the adverse effects associated with healthy tissues are decreased, and adverse effects are scaled back through enhanced permeability and retention effects. Lastly, future insights assisting nanotechnology in active therapeutics delivery and their scope in cancer chemotherapeutics have also been discussed.

纳米技术辅助化疗药物递送策略:最新进展和未来展望。
在追求癌症治疗的过程中,纳米技术工程已经成为最简单和最有效的手段,具有在目标部位提供抗肿瘤化疗药物的潜力。利用纳米技术给药可以提供从1纳米到1000纳米不等的纳米颗粒。缩小的尺寸通过增加药物扩散和降低外排速率来提高药物的生物利用度。这些纳米载体为根据药物及其疾病的化学和生物学特性进行修饰提供了巨大的空间。此外,这些纳米制剂有助于将药物活性分子靶向到所需的位置,并且近年来变得越来越重要。它们的现代应用彻底改变了许多治疗药物的抗肿瘤作用。纳米技术具有较高的载药效率、热稳定性、易于制造、生产成本低和大规模工业化生产等特点,使纳米技术成为药物分子递送的更好平台。此外,纳米载体技术辅助药物的相互作用降低了药物的毒性和治疗剂量,降低了药物耐受性,提高了肿瘤组织中的活性药物浓度,从而降低了健康组织中的浓度。基于纳米技术的药物正在被广泛探索,并在体内和体外系统中描述了有效的癌症管理,导致许多临床试验取得了有希望的结果。本文综述了近年来不同纳米载体在肿瘤治疗中的创新作用及应用。随后,它还描述了基本的发现和方法及其对癌症治疗的影响。与常规治疗相比,纳米药物可以显著提高抗肿瘤药物的治疗效果。因此,与健康组织相关的不良影响减少,并通过增强渗透性和保留作用减少不良影响。最后,本文还讨论了纳米技术在主动治疗药物递送中的应用前景,以及纳米技术在癌症化疗药物中的应用范围。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
期刊介绍: ACS Applied Bio Materials is an interdisciplinary journal publishing original research covering all aspects of biomaterials and biointerfaces including and beyond the traditional biosensing, biomedical and therapeutic applications. The journal is devoted to reports of new and original experimental and theoretical research of an applied nature that integrates knowledge in the areas of materials, engineering, physics, bioscience, and chemistry into important bio applications. The journal is specifically interested in work that addresses the relationship between structure and function and assesses the stability and degradation of materials under relevant environmental and biological conditions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信